Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07816900

Efficacy and Safety of Da-Cheng-Qi Decoction in Severe Acute Pancreatitis

Conditions: Severe Acute Pancreatitis, Intra-abdominal Hypertension

Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 60
Sponsor: Shanghai Jiao Tong University School of Medicine

Location: Emergency Department, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine Shanghai

Summary

This single-center prospective randomized controlled trial evaluated Da-Cheng-Qi Decoction (DCQD) as the acute-stage intervention of an integrated traditional Chinese and Western medicine whole-stage treatment protocol for severe acute pancreatitis (SAP). Sixty adults with SAP and intra-abdominal hypertension (IAP ≥ 12 mmHg) were randomized within 72 h of onset to receive standard Western treatment plus DCQD (100 mL via nasogastric tube twice daily for 7 days) or standard Western treatment alone. The primary outcome was intra-abdominal pressure measured by standardized bladder manometry every 12 h for 7 days. Secondary outcomes included stool output, length of hospital and ICU stay, and 28-day mortality. The trial was conducted at the Emergency Intensive Care Unit of Ruijin Hospital between April 2026 and July 2026.

Eligibility Criteria

Inclusion Criteria: * Severe acute pancreatitis diagnosed according to the revised Atlanta classification * Age 18-80 years * Disease onset within 72 h * Intra-abdominal hypertension (IAP \>= 12 mmHg) within 24 h of admission * Written informed consent obtained Exclusion Criteria: * Age \80 years * Pregnancy or lactation * Advanced malignancy (pancreatic, hepatobiliary, or gastrointestinal) * Severe chronic organ failure * Autoimmune disease or immunosuppression * Intra-abdominal hemorrhage * Urinary tract infection or prior bladder surgery (precluding bladder manometry) * Allergic constitution or known allergy to study medication * Psychiatric illness

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07816900). StuddyBuddy aggregates publicly available trial information.